Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2.
Dutta R, Zhang TY, Köhnke T, Thomas D, Linde M, Gars E, Stafford M, Kaur S, Nakauchi Y, Yin R, Azizi A, Narla A, Majeti R.
Dutta R, et al. Among authors: narla a.
J Clin Invest. 2020 Apr 1;130(4):1843-1849. doi: 10.1172/JCI133344.
J Clin Invest. 2020.
PMID: 31895700
Free PMC article.